FT

Franck Teyssier

Director of Commercialization Europe at ACEA Biosciences

Franck Teyssier has extensive experience in commercial roles within the biotechnology and life sciences sectors. Currently serving as the Director of Commercialization Europe at ACEA Biosciences since August 2017, Franck previously held the position of Technical Sales Specialist Manager for Western and Southern Europe at Thermo Fisher Scientific from January to August 2017. Prior to that, Franck was a Regional Manager at eBioscience from March 2010 to December 2016, overseeing sales in the French-speaking regions of Europe, including France, Switzerland, and Belgium. Franck began a career at Invitrogen as a Senior Technical Sales Specialist from October 2001 to September 2009.

Location

Paris, France

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


ACEA Biosciences

ACEA Biosciences is a biotechnology company founded in 2002 and headquartered in San Diego, California. ACEA is a pioneer in the development and commercialization of high-performance microelectronic systems for cell-based assays. ACEA has a world-class manufacturing operation centered in Hangzhou, Zhejiang Province, China.The Life TechnologyBusiness Unit developed ACEA’s proprietary real-time, label-free cell-based assay technology and launched the first product in 2004. The technology has been marketed globally under the xCELLigence brand. There are over 800 customers worldwide, and over 350 peer-reviewed publications using the xCELLigence technology.The newly launched iCELLigence instrument with wireless connectivity makes this innovative technology affordable to all users. In addition to the Life Technology Business Unit, ACEA also has a Therapeutics Business Unit which was launched in 2005.ACEA Therapeutics is focused on oncology drug discovery and development, leveraging the platform biosensor technology and proprietary small molecule library (> 1 million compounds) to bring novel therapeutics into the clinic. ACEA currently has one program in phase II clinical trials in China and numerous early clinical and preclinical leads. With its international reach, ACEA Biosciences continues to work closely with scientists throughout the world to bring innovation to the R&D and health care industries.